Cholesterol Corrects Altered Conformation of MHC-II Protein in Leishmania donovani Infected Macrophages: Implication in Therapy

PLoS Neglected Tropical Diseases

Volumn 10, Issue 5, 2016, Pages

  Roy, Koushik ^a   Mandloi, Sapan ^a   Chakrabarti, Saikat ^a   Roy, Syamal ^a,b  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b IUCAA Centre for Astronomy Research and Development   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; INTERLEUKIN 2; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; PERITONEUM EXUDATE; UNCLASSIFIED DRUG; HLA ANTIGEN CLASS 2; LIPOSOME; MEMBRANE LIPID; PROTEIN BINDING;

ALGORITHM; ANIMAL CELL; ANIMAL TISSUE; ANISOTROPY; ARTICLE; CONFORMATIONAL TRANSITION; ENERGY TRANSFER; ENZYME LINKED IMMUNOSORBENT ASSAY; HYBRIDOMA; LEISHMANIA DONOVANI; LEISHMANIASIS; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMBRANE FLUIDITY; MOLECULAR DOCKING; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; T LYMPHOCYTE ACTIVATION; ANIMAL; ANTIGEN PRESENTATION; BAGG ALBINO MOUSE; CBA MOUSE; CELL MEMBRANE; CHEMISTRY; HELPER CELL; IMMUNOLOGY; LEISHMANIASIS, VISCERAL; METABOLISM; PARASITOLOGY;

ANIMALS; ANTIGEN PRESENTATION; CELL MEMBRANE; CHOLESTEROL; HISTOCOMPATIBILITY ANTIGENS CLASS II; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LIPOSOMES; MACROPHAGES; MEMBRANE LIPIDS; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; MOLECULAR DYNAMICS SIMULATION; PROTEIN BINDING; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84971590292     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0004710     Document Type: Article

References (60)

1. Basak SK, Saha B, Bhattacharya A, Roy S, Immunobiological studies on experimental visceral leishmaniasis. II. Adherent cell-mediated down-regulation of delayed-type hypersensitivity response and up-regulation of B cell activation. Eur J Immunol. 1992;22(8):2041–5. Epub 1992/08/01. doi: 10.1002/eji.18302208131386313.
2. Neogy AB, Nandy A, Ghosh Dastidar B, Chowdhury AB, Modulation of the cell-mediated immune response in kala-azar and post-kala-azar dermal leishmaniasis in relation to chemotherapy. Ann Trop Med Parasitol. 1988;82(1):27–34. Epub 1988/02/01. 2840867.
3. Beil WJ, Meinardus-Hager G, Neugebauer DC, Sorg C, Differences in the onset of the inflammatory response to cutaneous leishmaniasis in resistant and susceptible mice. J Leukocyte Biol. 1992;52(2):135–42. Epub 1992/08/01. 1506767.
4. Chakraborty D, Banerjee S, Sen A, Banerjee KK, Das P, Roy S, Leishmania donovani affects antigen presentation of macrophage by disrupting lipid rafts. J Immunol. 2005;175(5):3214–24. Epub 2005/08/24. 16116212.
5. Banerjee S, Ghosh J, Sen S, Guha R, Dhar R, Ghosh M, et al. Designing therapies against experimental visceral leishmaniasis by modulating the membrane fluidity of antigen-presenting cells. Infect Immun. 2009;77(6):2330–42. Epub 2009/03/18. doi: 10.1128/IAI.00057-0919289510; PubMed Central PMCID: PMC2687339.
6. Roy K, Naskar K, Ghosh M, Roy S, Class II MHC/peptide interaction in Leishmania donovani infection: implications in vaccine design. J Immunol. 2014;192(12):5873–80. Epub 2014/05/23. doi: 10.4049/jimmunol.130297024850723.
7. Sen S, Roy K, Mukherjee S, Mukhopadhyay R, Roy S, Restoration of IFNgammaR subunit assembly, IFNgamma signaling and parasite clearance in Leishmania donovani infected macrophages: role of membrane cholesterol. PLoS Path. 2011;7(9):e1002229. Epub 2011/09/21. doi: 10.1371/journal.ppat.100222921931549; PubMed Central PMCID: PMC3169561.
8. Ghosh J, Bose M, Roy S, Bhattacharyya SN, Leishmania donovani targets Dicer1 to downregulate miR-122, lower serum cholesterol, and facilitate murine liver infection. Cell host & microbe. 2013;13(3):277–88. Epub 2013/03/19. doi: 10.1016/j.chom.2013.02.00523498953; PubMed Central PMCID: PMC3605572.
9. Shinitzky M, Inbar M, Difference in microviscosity induced by different cholesterol levels in the surface membrane lipid layer of normal lymphocytes and malignant lymphoma cells. J Mol Biol. 1974;85(4):603–15. Epub 1974/01/05. 4851371.
10. Ghosh M, Roy K, Das Mukherjee D, Chakrabarti G, Roy Choudhury K, Roy S, Leishmania donovani infection enhances lateral mobility of macrophage membrane protein which is reversed by liposomal cholesterol. PLoS neglected tropical diseases. 2014;8(12):e3367. Epub 2014/12/05. doi: 10.1371/journal.pntd.000336725474261; PubMed Central PMCID: PMC4256160.
11. Roy K, Ghosh M, Pal TK, Chakrabarti S, Roy S, Cholesterol lowering drug may influence cellular immune response by altering MHC II function. J Lipid Res. 2013;54(11):3106–15. Epub 2013/09/17. doi: 10.1194/jlr.M04195424038316; PubMed Central PMCID: PMC3793615.
12. Epand RM, Cholesterol and the interaction of proteins with membrane domains. Progress in lipid research. 2006;45(4):279–94. Epub 2006/04/01. doi: 10.1016/j.plipres.2006.02.00116574236.
13. Harris JR, SpringerLink (Online service)Cholesterol Binding and Cholesterol Transport Proteins: Structure and Function in Health and Disease.
14. Luo X, Sharma D, Inouye H, Lee D, Avila RL, Salmona M, et al. Cytoplasmic domain of human myelin protein zero likely folded as beta-structure in compact myelin. Biophys J. 2007;92(5):1585–97. Epub 2006/12/05. doi: 10.1529/biophysj.106.09472217142269; PubMed Central PMCID: PMC1796833.
15. Hanson MA, Cherezov V, Griffith MT, Roth CB, Jaakola VP, Chien EY, et al. A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. Structure. 2008;16(6):897–905. Epub 2008/06/13. doi: 10.1016/j.str.2008.05.00118547522; PubMed Central PMCID: PMC2601552.
16. Gimpl G, Cholesterol-protein interaction: methods and cholesterol reporter molecules. Sub-cellular biochemistry. 2010;51:1–45. Epub 2010/03/10. doi: 10.1007/978-90-481-8622-8_120213539.
17. Schroeder C, Cholesterol-binding viral proteins in virus entry and morphogenesis. Sub-cellular biochemistry. 2010;51:77–108. Epub 2010/03/10. doi: 10.1007/978-90-481-8622-8_320213541.
18. Fosslien E, Mitochondrial medicine—molecular pathology of defective oxidative phosphorylation. Annals of clinical and laboratory science. 2001;31(1):25–67. Epub 2001/04/21. 11314862.
19. Olaposi O, Tsuyoshi H, Theoretical Dynamics and Energetics of HLA-A2/SLYNTVATL Interaction. American Journal of Bioinformatics Research. 2015. 5: 1–8.
20. Landais D, Matthes H, Benoist C, Mathis D, A molecular basis for the Ia.2 and Ia.19 antigenic determinants. Proceedings of the National Academy of Sciences of the United States of America. 1985;82(9):2930–4. Epub 1985/05/01. 2581258; PubMed Central PMCID: PMC397680.
21. Landias D, Beck BN, Buerstedde JM, Degraw S, Klein D, Koch N, et al. The assignment of chain specificities for anti-Ia monoclonal antibodies using L cell transfectants. J Immunol. 1986;137(9):3002–5. Epub 1986/11/01. 3463623.
22. Braunstein NS, Germain RN, Allele-specific control of Ia molecule surface expression and conformation: implications for a general model of Ia structure-function relationships. Proceedings of the National Academy of Sciences of the United States of America. 1987;84(9):2921–5. Epub 1987/05/01. 3033670; PubMed Central PMCID: PMC304772.
23. Cosson P, Bonifacino JS, Role of transmembrane domain interactions in the assembly of class II MHC molecules. Science. 1992;258(5082):659–62. Epub 1992/10/23. 1329208.
24. Busman-Sahay K, Sargent E, Harton JA, Drake JR, The Ia.2 epitope defines a subset of lipid raft-resident MHC class II molecules crucial to effective antigen presentation. J Immunol. 2011;186(12):6710–7. Epub 2011/05/06. doi: 10.4049/jimmunol.110033621543648.
25. Lindgren H, Shen H, Zingmark C, Golovliov I, Conlan W, Sjostedt A, Resistance of Francisella tularensis strains against reactive nitrogen and oxygen species with special reference to the role of KatG. Infect Immun. 2007;75(3):1303–9. Epub 2007/01/11. doi: 10.1128/IAI.01717-0617210667; PubMed Central PMCID: PMC1828546.
26. Puddu P, Fantuzzi L, Borghi P, Varano B, Rainaldi G, Guillemard E, et al. IL-12 induces IFN-gamma expression and secretion in mouse peritoneal macrophages. J Immunol. 1997;159(7):3490–7. Epub 1997/10/08. 9317148.
27. Haldar AK, Yadav V, Singhal E, Bisht KK, Singh A, Bhaumik S, et al. Leishmania donovani isolates with antimony-resistant but not -sensitive phenotype inhibit sodium antimony gluconate-induced dendritic cell activation. PLoS Path. 2010;6(5):e1000907. Epub 2010/05/27. doi: 10.1371/journal.ppat.100090720502630; PubMed Central PMCID: PMC2873921.
28. De T, Roy S, Infectivity and attenuation of Leishmania donovani promastigotes: association of galactosyl transferase with loss of parasite virulence. J Parasitol. 1999;85(1):54–9. 10207363.
29. Shinitzky M, Barenholz Y, Fluidity parameters of lipid regions determined by fluorescence polarization. Biochimica et biophysica acta. 1978;515(4):367–94. Epub 1978/12/15. 365237.
30. Muraille E, Gounon P, Cazareth J, Hoebeke J, Lippuner C, Davalos-Misslitz A, et al. Direct visualization of peptide/MHC complexes at the surface and in the intracellular compartments of cells infected in vivo by Leishmania major. PLoS Path. 2010;6(10):e1001154. Epub 2010/10/27. doi: 10.1371/journal.ppat.100115420976202; PubMed Central PMCID: PMC2954901.
31. Pedrazzini T, Sette A, Albertson M, Grey HM, Free ligand-induced dissociation of MHC-antigen complexes. J Immunol. 1991;146(10):3496–501. Epub 1991/05/15. 2026878.
32. Harding CV, Roof RW, Unanue ER, Turnover of Ia-peptide complexes is facilitated in viable antigen-presenting cells: biosynthetic turnover of Ia vs. peptide exchange. Proceedings of the National Academy of Sciences of the United States of America. 1989;86(11):4230–4. Epub 1989/06/01. 2786208; PubMed Central PMCID: PMC287424.
33. Chaves FA, Sant AJ, Measurement of peptide dissociation from MHC class II molecules. Current protocols in immunology / edited by John E Coligan [et al]. 2007;Chapter 18:Unit 18 4. Epub 2008/04/25. doi: 10.1002/0471142735.im1814s7718432989.
34. Vacchino JF, McConnell HM, Peptide binding to active class II MHC protein on the cell surface. J Immunol. 2001;166(11):6680–5. Epub 2001/05/22. 11359823.
35. Pronk S, Pall S, Schulz R, Larsson P, Bjelkmar P, Apostolov R, et al. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics. 2013;29(7):845–54. Epub 2013/02/15. doi: 10.1093/bioinformatics/btt05523407358; PubMed Central PMCID: PMC3605599.
36. Wolf MG, Hoefling M, Aponte-Santamaria C, Grubmuller H, Groenhof G, g_membed: Efficient insertion of a membrane protein into an equilibrated lipid bilayer with minimal perturbation. Journal of computational chemistry. 2010;31(11):2169–74. Epub 2010/03/26. doi: 10.1002/jcc.2150720336801.
37. Berendsen HJC, Postma JPM, van Gunsteren WF, Hermans J, Interactions models for water in relation to protein hydration. Reidel Publishing Company, Dordrecht. 1981.
38. Oostenbrink C, Villa A, Mark AE, van Gunsteren WF, A biomolecular force field based on the free enthalpy of hydration and solvation: the GROMOS force-field parameter sets 53A5 and 53A6. Journal of computational chemistry. 2004;25(13):1656–76. Epub 2004/07/21. doi: 10.1002/jcc.2009015264259.
39. Van Gunsteren WF, Berendsen HJ, A leap-frog algorithm for stochastic dynamics. Mol Simul.1988;1(3):173–185.
40. Hess B, Bekker H, Berendsen HJC, Fraaije JGEM, LINCS: A linear constraint solver for molecular simulations. J. Comput. Chem. 1997; 18:1463–1472.
41. Darden T, York D, Pedersen L, Particle mesh Ewald: An N-log(N) method for Ewald sums in large systems. J Chem Phys. 1993;98:10089–10092.
42. Hoover WG, Canonical dynamics: Equilibrium phase-space distributions. Physical review A. 1985;31(3):1695–7. Epub 1985/03/01. 9895674.
43. Parrinello M, Rahman A, Polymorphic Transitions in Single Crystals: A New Molecular Dynamics Method. J. Appl. Phys. 1981; 52:7182.
44. Bakan A, Meireles LM, Bahar I, ProDy: protein dynamics inferred from theory and experiments. Bioinformatics. 2011;27(11):1575–7. Epub 2011/04/08. doi: 10.1093/bioinformatics/btr16821471012; PubMed Central PMCID: PMC3102222.
45. Krissinel E, Henrick K, Inference of macromolecular assemblies from crystalline state. J Mol Biol. 2007;372(3):774–97. Epub 2007/08/08. doi: 10.1016/j.jmb.2007.05.02217681537.
46. Incardona JP, Eaton S, Cholesterol in signal transduction. Curr Opin Cell Biol. 2000;12(2):193–203. Epub 2000/03/14. 10712926.
47. Bastiaanse EM, Hold KM, Van der Laarse A, The effect of membrane cholesterol content on ion transport processes in plasma membranes. Cardiovascular research. 1997;33(2):272–83. Epub 1997/02/01. 9074689.
48. Ghosh J, Lal CS, Pandey K, Das VN, Das P, Roychoudhury K, et al. Human visceral leishmaniasis: decrease in serum cholesterol as a function of splenic parasite load. Ann Trop Med Parasitol. 2011;105(3):267–71. Epub 2011/08/02. doi: 10.1179/136485911X1289983868356621801506; PubMed Central PMCID: PMC4090785.
49. Ghosh J, Das S, Guha R, Ghosh D, Naskar K, Das A, et al. Hyperlipidemia offers protection against Leishmania donovani infection: role of membrane cholesterol. J Lipid Res. 2012;53(12):2560–72. Epub 2012/10/13. doi: 10.1194/jlr.M02691423060454; PubMed Central PMCID: PMC3494257.
50. Tonks A, Morris RH, Price AJ, Thomas AW, Jones KP, Jackson SK, Dipalmitoylphosphatidylcholine modulates inflammatory functions of monocytic cells independently of mitogen activated protein kinases. Clin Exp Immunol. 2001;124(1):86–94. Epub 2001/05/22. 11359446; PubMed Central PMCID: PMC1906030.
51. Tonks AJ, Tonks A, Morris RH, Jones KP, Jackson SK, Regulation of platelet-activating factor synthesis in human monocytes by dipalmitoyl phosphatidylcholine. J Leukocyte Biol. 2003;74(1):95–101. Epub 2003/07/02. 12832447.
52. Brannigan G, Henin J, Law R, Eckenhoff R, Klein ML, Embedded cholesterol in the nicotinic acetylcholine receptor. Proceedings of the National Academy of Sciences of the United States of America. 2008;105(38):14418–23. Epub 2008/09/05. doi: 10.1073/pnas.080302910518768796; PubMed Central PMCID: PMC2567199.
53. Khelashvili G, Grossfield A, Feller SE, Pitman MC, Weinstein H, Structural and dynamic effects of cholesterol at preferred sites of interaction with rhodopsin identified from microsecond length molecular dynamics simulations. Proteins. 2009;76(2):403–17. Epub 2009/01/29. doi: 10.1002/prot.2235519173312; PubMed Central PMCID: PMC4101808.
54. Paila YD, Tiwari S, Sengupta D, Chattopadhyay A, Molecular modeling of the human serotonin(1A) receptor: role of membrane cholesterol in ligand binding of the receptor. Molecular bioSystems. 2011;7(1):224–34. Epub 2010/10/23. doi: 10.1039/c0mb00148a20967314.
55. Sengupta D, Chattopadhyay A, Identification of cholesterol binding sites in the serotonin1A receptor. The journal of physical chemistry B. 2012;116(43):12991–6. Epub 2012/10/17. doi: 10.1021/jp309888u23067252.
56. Prasanna X, Chattopadhyay A, Sengupta D, Cholesterol modulates the dimer interface of the beta(2)-adrenergic receptor via cholesterol occupancy sites. Biophys J. 2014;106(6):1290–300. Epub 2014/03/25. doi: 10.1016/j.bpj.2014.02.00224655504; PubMed Central PMCID: PMC3984991.
57. Saha B, Das G, Vohra H, Ganguly NK, Mishra GC, Macrophage-T cell interaction in experimental visceral leishmaniasis: failure to express costimulatory molecules on Leishmania-infected macrophages and its implication in the suppression of cell-mediated immunity. Eur J Immunol. 1995;25(9):2492–8. Epub 1995/09/01. doi: 10.1002/eji.18302509137589116.
58. Jacobs DR, JrWhy is low blood cholesterol associated with risk of nonatherosclerotic disease death?Annu Rev Public Health. 1993;14:95–114. Epub 1993/01/01. doi: 10.1146/annurev.pu.14.050193.0005238323608.
59. Perez-Guzman C, Vargas MH, Quinonez F, Bazavilvazo N, Aguilar A, A cholesterol-rich diet accelerates bacteriologic sterilization in pulmonary tuberculosis. Chest. 2005;127(2):643–51. Epub 2005/02/12. doi: 10.1378/chest.127.2.64315706008.
60. Elias ER, Irons MB, Hurley AD, Tint GS, Salen G, Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS). American journal of medical genetics. 1997;68(3):305–10. Epub 1997/01/31. 9024564.